Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Corbion NV    CRBN   NL0010583399

CORBION NV

(CRBN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Corbion : First Quarter

share with twitter share with LinkedIn share with facebook
04/30/2020 | 01:08am EDT

PRESS RELEASE

DATE 30 April 2020

Corbion nv

Piet Heinkade 127

Amsterdam, 1019 GM • PO Box 349

1000 AH Amsterdam

The Netherlands

T +31 (0)20 590 6911 press@corbion.com

www.corbion.com

Corbion Q1 2020 Interim Management Statement

Corbion reported sales of € 256.3 million in the first quarter of 2020, an increase of 12.0% due to organic sales growth of 9.6% and positive currency effects. Adjusted EBITDA increased organically by 24.1% to € 44.4 million due to improvements in all business segments.

"Our purpose 'preserving food, food production, health and the planet' has never been more meaningful and relevant than during the current pandemic crisis. I could not be prouder of our teams across the globe, producing record volumes under very challenging circumstances, always ensuring health and safety of our colleagues as our first priorities. All business segments improved significantly over last year, both in sales and profits. The COVID-19 crisis pushed up sales even further in March, building on a strong start of the year. Consumer buying patterns shifted from out-of-home channels to food retail. Additionally, our customers were securing supplies to ensure production continuity. As we are implementing our new strategic plan Advance 2025, I am confident in Corbion's fundamentals and business model resilience to continue to create value in a sustainable way", commented Olivier Rigaud, CEO.

Key financial highlights first quarter of 2020

  • Net sales growth was 12.0%; organic growth was 9.6% (11.1% for core activities)
  • Adjusted EBITDA was € 44.4 million, an organic increase of 24.1%
  • Adjusted EBITDA margin was 17.3% (17.7% for core activities)
  • Operating result was € 27.4 million, an organic increase of 34.6%

€ million

YTD 2020

YTD 2019

Total growth

Organic growth

Net sales

256.3

228.9

12.0%

9.6%

Adjusted EBITDA

44.4

34.9

27.2%

24.1%

Adjusted EBITDA margin

17.3%

15.2%

Operating result

27.4

20.1

36.3%

34.6%

Registered, Amsterdam no. 33006580

PAGE 1 of 5

PRESS RELEASE

Segment information

Core activities

Net sales in the core activities, which encompasses Sustainable Food Solutions, Lactic Acid & Specialties, and Incubator, increased by 15.0%, driven by organic net sales growth of 11.1% and positive currency effects. The adjusted EBITDA margin increased from 15.4% to 17.7%. We estimate that the COVID-19-pandemic has had a positive impact on our organic net sales growth in the core activities of approximately 300 bps, even though the exact magnitude is hard to determine. Over the month of March, this impact was predominantly seen in our Sustainable Food Solutions segment.

Sustainable Food Solutions

Net sales increased organically by 8.3%. In Functional Systems we saw particularly strong growth in bread solutions as customers were securing supply and accommodating the consumer shift to packaged bread. In Preservation, the higher consumer demand for meat products with extended shelf-life drove our growth. The adjusted EBITDA margin increased from 17.6% to 18.0%.

Lactic Acid & Specialties

Net sales increased organically by 14.7%. The strong increase was driven by high growth in lactic acid (also to the Total Corbion PLA JV). Lactate sales to the pharma industry grew, as well as the ester (solvents) sales, driven by a substantial sales recovery to the semiconductor industry.

Medical polymer sales were at a similar level as last year's record quarter. The adjusted EBITDA margin in Lactic Acid & Specialties increased from 23.6% to 25.0%.

Incubator

Net sales increased by 86.6%, mostly driven by higher AlgaPrime DHA (omega-3) sales. The increase was supported by the launch of a liquid version of our product, which makes it more convenient for some of our customers to include in the fish feed. Adjusted EBITDA losses declined from € -7.7 million in Q1 2019 to € -5.7 million in Q1 2020, supported by fixed cost savings.

Non-core activities

Net sales increased organically by 2.7%. This was the balance between higher emulsifier sales, slightly higher frozen dough sales, and lower co-packing blending which is being phased out. The adjusted EBITDA margin in non-core activities increased from 14.4% to 15.6%.

Registered, Amsterdam no. 33006580

PAGE 2 of 5

PRESS RELEASE

COVID-19 update

  • All plants are in operation, with measures in place to secure everyone's health as first priority. Because of our position as a key supplier in the food and pharma supply chain, our plants in most countries were qualified as 'essential', enabling our people and contractors to come to the plant and continue their activities, and enabling us to serve our customers in the best possible way. In one of our plants a minor production line has temporarily been shut down to make the necessary adjustments as a safe working distance could not be maintained.
  • COVID-19infections among Corbion employees have been very limited. Contingency plans to ensure business continuity in case of increased infection levels have been put in place.
  • We experienced only minor raw material supply issues, but all were resolved. We are continuously managing our in- and outbound supply chain and taking appropriate action to mitigate risk. We have increased inventory levels of strategic raw materials.
  • Our net debt/EBITDA at end of Q1 was 2.0x (unchanged from year-end 2019), well below our loan covenants. From a refinancing perspective our funding is secure. As a precautionary measure we have increased our cash balances by partially drawing on our revolving credit facility.

Outlook FY2020 (for core activities)

Even though our Q1 performance was better than the indicated annual guidance levels, we don't expect these growth and profitability levels to be repeated in the coming quarters given the uncertainty at this moment about the development of the COVID-19 pandemic and its impact on the general economic climate going forward. At this stage we leave our annual guidance for our core activities unchanged: Organic net sales growth in the 4-7% range, and adjusted EBITDA margin to be stable vs FY19 at ~15%.

Financial results

Total

Net sales

Total

Currency

growth at

Acquisitions/

Organic

Price/Mix

Volume

growth

constant

(Divestments)

currency

YTD 2020 vs YTD 2019

Core

15.0%

1.3%

13.7%

2.6%

11.1%

-3.6%

15.3%

- Sustainable Food Solutions

13.4%

1.1%

12.3%

4.0%

8.3%

-0.6%

9.0%

- Lactic Acid & Specialties

16.7%

2.0%

14.7%

0.0%

14.7%

-8.2%

25.0%

- Incubator

64.3%

-22.3%

86.6%

0.0%

86.6%

-17.1%

125.0%

Non-Core

-1.4%

2.9%

-4.3%

-7.0%

2.7%

-1.7%

4.5%

Total

12.0%

1.6%

10.4%

0.8%

9.6%

-3.4%

13.4%

Registered, Amsterdam no. 33006580

PAGE 3 of 5

PRESS RELEASE

€ million

YTD 2020

YTD 2019

Growth YTD

Net Sales

Core

215.2

187.2

15.0%

- Sustainable Food Solutions

136.2

120.1

13.4%

- Lactic Acid & Specialties

76.7

65.7

16.7%

- Incubator

2.3

1.4

64.3%

Non-Core

41.1

41.7

-1.4%

Total Net Sales

256.3

228.9

12.0%

Adjusted EBITDA

Core

38.0

28.9

31.5%

- Sustainable Food Solutions

24.5

21.1

16.1%

- Lactic Acid & Specialties

19.2

15.5

23.9%

- Incubator

(5.7)

(7.7)

26.0%

Non-Core

6.4

6.0

6.7%

Total Adjusted EBITDA

44.4

34.9

27.2%

Adjusted EBITDA margin

Core

17.7%

15.4%

- Sustainable Food Solutions

18.0%

17.6%

- Lactic Acid & Specialties

25.0%

23.6%

- Incubator

-247.8%

-550.0%

Non-Core

15.6%

14.4%

Total Adjusted EBITDA margin

17.3%

15.2%

Registered, Amsterdam no. 33006580

PAGE 4 of 5

PRESS RELEASE

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

For more information, please contact:

Analysts and investors:

Jeroen van Harten, Director Investor Relations +31 (0)20 590 6293, +31 (0)6 21 577 086

Press:

Tanno Massar, Director Corporate Communications +31 (0)20 590 6325, +31 (0)6 11 589 121

Background information:

Corbion is the global market leader in lactic acid, lactic acid derivatives, and a leading company in emulsifiers, functional enzyme blends, minerals, vitamins and algae ingredients. We develop sustainable ingredient solutions to improve the quality of life for people today and for future generations. For over 100 years, we have been uncompromising in our commitment to safety, quality, innovation and performance. Drawing on our deep application and product knowledge, we work side-by-side with customers to make our cutting-edge technologies work for them. Our solutions help differentiate products in markets such as food, home & personal care, animal nutrition, pharmaceuticals, medical devices, and bioplastics. In 2018, Corbion generated annual sales of € 897.2 million and had a workforce of 2,040 FTE. Corbion is listed on Euronext Amsterdam. For more information: www.corbion.com

Registered, Amsterdam no. 33006580

PAGE 5 of 5

Disclaimer

Corbion NV published this content on 30 April 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 April 2020 05:07:14 UTC

share with twitter share with LinkedIn share with facebook
Latest news on CORBION NV
07/01CORBION NV : Ex-dividend day for final dividend
FA
06/29Corbion General Shareholders Meeting approves Supervisory Board appointments ..
GL
05/18CORBION : published agenda for virtual AGM
AQ
04/30CORBION : First Quarter
PU
04/30CORBION NV : Slide show Q1 results
CO
04/30CORBION NV : 1st quarter results
CO
03/26CORBION : postpones AGM
AQ
03/18CORBION N : Message from our CEO
PU
03/09CORBION N : Fourth Quarter
PU
03/09CORBION STRATEGY UPDATE : Advance 2025
AQ
More news
Financials
Sales 2020 1 021 M 1 153 M 1 153 M
Net income 2020 57,5 M 65,0 M 65,0 M
Net Debt 2020 325 M 368 M 368 M
P/E ratio 2020 33,5x
Yield 2020 1,77%
Capitalization 1 885 M 2 133 M 2 129 M
EV / Sales 2019
EV / Sales 2020 2,16x
Nbr of Employees 2 091
Free-Float 93,8%
Chart CORBION NV
Duration : Period :
Corbion NV Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CORBION NV
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 32,89 €
Last Close Price 32,05 €
Spread / Highest target 12,3%
Spread / Average Target 2,61%
Spread / Lowest Target -6,40%
EPS Revisions
Managers
NameTitle
Olivier Rigaud Chief Executive Officer
Mathieu Vrijsen Chairman-Supervisory Board
Jacqueline van Lemmen Executive Vice President-Operations
Eddy van Rhede van der Kloot Chief Financial Officer
Marcel Wubbolts Chief Science & Sustainability Officer
Sector and Competitors
1st jan.Capitalization (M$)
CORBION NV13.98%2 133
ECOLAB INC.3.97%57 093
GIVAUDAN19.50%35 516
SIKA AG4.81%28 737
EMS-CHEMIE HOLDING AG20.03%19 008
SYMRISE AG13.43%16 302